CSI Market
Sign In | Register

Opko Health Inc (OPK) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access OPK quarterly Cash Flow →
Examining cash flow movements between Opko Health Inc and Dec 31 2021 reveals how Dec 31 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-225.68
Depreciation & amortization91.63
Amortization of Other Assets5.23
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived1.01
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-4.12
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total-104.82
Share-based Compensation10.71
Income (Loss) from Equity Method Investments0.03
Paid-in-Kind Interest66.26
Provision Recovery Of For Doubtful Accounts-
Provision For Reversal Of Inventory Reserves-
Unrealized Gain From Warrants-
Revenue From Receipt Of Equity-
Fair Value Of Contingent Consideration Period Increase-
Gain Loss On Repurchase Of Debt Instrument-
Gain Loss On Derivative Instruments Net Pretax-
Increase Decreasein Foreign Currency Measurement-
Gain Loss On Conversion Of Debt-
Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments0.62
Increase Decrease In Foreign Currency Measurement0.18
Increase Decrease In Contract With Customer Liability-
Income taxes-15.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable30.21
Increase (Decrease) in Accounts Payable-14.22
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-47.84
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-5.42
Other Working Capital0.02
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities32.65
Discontinued operations0.00
Net Cash flow from Operating Activities-178.54
Investing Activities
Capital Expenditures-12.28
Sale of Capital Items0.29
Proceeds from Maturities, Prepayments and Calls of Short-term Investments0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Payments To Acquire Product-
Maturities Of Short Term Marketable Securities-
Proceeds From Sale Of Equity Securities Fv Ni-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments52.18
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Interest in Subsidiaries and Affiliates-7.67
Proceeds from Divestiture of Businesses197.77
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities230.30
Financing Activities
Short-term debt Net-8.38
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-62.21
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-47.04
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Issuance Of Warrants And Preferred Stock Series D-
Repayment Of Bridge Loan With Related Party-
Repayments Of Lines Of Credit And Capital Lease Obligations-
Proceeds From Issuance of Stock Options Exercised and Issuance of Warrants-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Stock Options Exercised Net Of Tax Withholdings-
Proceeds From Stock Options Exercised Net-
Proceeds From Repurchase Of Stock Options And Warrants Exercised-0.26
Settlement Of Convertible Notes-0.17
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-118.06
Effect of exchange rate on cash flow3.43
Discontinued operations0.00
Free Cash Flow-190.53
Total Cash Flow-62.87
4 historic quarters locked

Sign in to unlock the full Opko Health Inc cash flow history.

Sign In Create Free Account

About Opko Health Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: opk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-076596

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License